Product
10XB-101
Aliases
10xB-101, 6%, 10XB-101 Solution for Injection, 10XB-101 Solution for Injection, 6.0%
4 clinical trials
3 indications
Indication
LipodystrophyIndication
Submental fatIndication
Antenatal Congenital MalformationsClinical trial
A Randomized, Double-Blind, Bilateral Comparison Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Bilateral Flank AdiposityStatus: Active (not recruiting), Estimated PCD: 2024-10-28
Clinical trial
A Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Submental FatStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
A Multi-Center, Open Label, Single Ascending Dose Safety and Tolerability Study of Subcutaneously Administered 10XB-101 in Adult Subjects With Excessive Submental FatStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are DiscoveredStatus: Recruiting, Estimated PCD: 2025-03-01